Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy
Author:
Funder
Novo Nordisk Fonden
Norwegian Cancer Society
Swedish Cancer Society
Merck KGaA
Darmstadt
Sanofi
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/advance-article-pdf/doi/10.1093/annonc/mdz139/28698206/mdz139.pdf
Reference29 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA;Bray;Cancer J Clin,2018
2. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;de Gramont;J Clin Oncol,2000
3. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study;Bokemeyer;Ann Oncol,2011
4. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials;Arnold;Ann Oncol,2017
5. Colorectal cancer heterogeneity and targeted therapy: a case for molecular disease subtypes;Linnekamp;Cancer Res,2015
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer;Targeted Oncology;2024-01
2. Comprehensive Analysis of Cell-Free DNA Fragmentation Across Cancer Stages;2023-11-17
3. Comprehensive Analysis of Cell-Free DNA Fragmentation Across Cancer Stages;2023-11-08
4. Circulating DNA and frequency of colorectal cancer brain metastases in a presumed high-risk group;Scientific Reports;2023-10-30
5. Pre-analytical conditions and implementation of quality control steps in liquid biopsy analysis;Critical Reviews in Clinical Laboratory Sciences;2023-07-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3